Journal
JOURNAL OF IMMUNOLOGY
Volume 187, Issue 11, Pages 5693-5702Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1102267
Keywords
-
Categories
Funding
- Israeli Ministry of Science and Technology/German Cancer Research Center
- United States Israel Binational Science Foundation
- National Institutes of Health [R01 CA-083859]
Ask authors/readers for more resources
NK cells play an important role in the early immune response to cancer. The NKp44 activating receptor is the only natural cytotoxicity receptor that is expressed exclusively by primate NK cells, yet its cellular ligands remain largely unknown. Proliferating cell nuclear Ag (PCNA) is overexpressed in cancer cells. In this study, we show that the NKp44 receptor recognizes PCNA. Their interaction inhibits NK cell function through NKp44/ITIM. The physical interaction of NKp44 and PCNA is enabled by recruitment of target cell PCNA to the NK immunological synapse. We demonstrate that PCNA promotes cancer survival by immune evasion through inhibition of NKp44-mediated NK cell attack. The Journal of Immunology, 2011, 187: 5693-5702.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available